JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB144859

Papaverine hydrochloride, PDE10A inhibitor

Be the first to review this product! Submit a review

|

(0 Publication)

MW 375.8 Da, Purity >95%. Potent and selective PDE10A inhibitor (IC50 values are 17 and 284 nM for PDE10A and PDE3A respectively). Shows smooth muscle relaxant, antispasmodic and vasodilatory effects in vivo. Orally active.
1 Images
Chemical Structure - Papaverine hydrochloride, PDE10A inhibitor (AB144859)
  • Chemical Structure

Lab

Chemical Structure - Papaverine hydrochloride, PDE10A inhibitor (AB144859)

2D chemical structure image of ab144859, Papaverine hydrochloride, PDE10A inhibitor

Key facts

CAS number

61-25-6

Purity

>95%

Form

Solid

form

Molecular weight

375.8 Da

Molecular formula

C<sub>2</sub><sub>0</sub>H<sub>2</sub><sub>1</sub>NO<sub>4</sub>.ClH

PubChem

6084

Nature

Synthetic

Solubility

Soluble in ethanol

Soluble in DMSO

Biochemical name

Papaverine hydrochloride

Biological description

Potent and selective PDE10A inhibitor (IC50 values are 17 and 284 nM for PDE10A and PDE3A respectively). Shows smooth muscle relaxant, antispasmodic and vasodilatory effects in vivo. Orally active.

Canonical smiles

COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC.Cl

InChi

InChI=1S/C20H21NO4.ClH/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16;/h5-8,10-12H,9H2,1-4H3;1H

InChiKey

UOTMYNBWXDUBNX-UHFFFAOYSA-N

IUPAC Name

1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline;hydrochloride

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store in the dark|Store under desiccating conditions|This product is air and light sensitive and impurities can occur as a result of air oxidation or due to metabolism by microbes

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Gli3 Cytochrome P450 3A4 (CYP3A4) and Estrogen-Related Receptor Alpha (ERRα) are distinct yet significant biological targets with specific mechanical functions. Gli3 operates as a transcription factor belonging to the GLI family with a mass around 158 kDa and it is predominantly expressed in the brain. CYP3A4 is a critical enzyme weighing approximately 57 kDa found abundantly in the liver and intestine responsible for the metabolism of many xenobiotics and drugs. ERRα with a mass about 49 kDa functions as a nuclear receptor and is highly expressed in tissues with high metabolic demand such as the heart and muscle.
Biological function summary

Gli3 plays a fundamental role in the modulation of the Hedgehog signaling pathway involving itself in the transcription of target genes that are important for development. It often functions in complex with other GLI proteins modulating gene expression. CYP3A4 contributes as the main enzyme for drug metabolism influencing the pharmacokinetics of countless substances and transforming them into inactive or active forms. ERRα regulates gene expression involved in mitochondrial biogenesis and oxidative metabolism often interacting as a monomer rather than forming a complex.

Pathways

Gli3 is significant in the Hedgehog pathway closely interacting with proteins like Patched and Smoothened to regulate cellular growth and differentiation. CYP3A4 is integral to the metabolic pathway of drug metabolism and detoxification collaborating with proteins such as NADPH-cytochrome P450 reductase. While ERRα is pivotal in the estrogen signaling pathway influencing cellular energy balance and collaborating with coactivators like peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α).

Gli3 mutations and misregulation associate strongly with developmental disorders such as Greig cephalopolysyndactyly syndrome often along with other GLI proteins. CYP3A4's involvement in drug metabolism connects it to disorders such as drug-induced liver injury where it often works interactively with other cytochrome P450 enzymes like CYP2C19. ERRα's influence on energy metabolism links it to metabolic disorders such as type 2 diabetes interacting with proteins involved in metabolic pathways.

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com